Pfizer to Buy King Pharmaceuticals for $3.6 Billion

Oct. 12, 2010
Pfizer said deal will help company in 'offering both currently marketed opioid and non-opioid products, as well as a pipeline spanning stages of clinical development.'

In a bid to boost its position in the pain-relief market, Pfizer, the world's largest drug maker, said on Oct. 12 that it will buy King Pharmaceuticals for $3.6 billion.

Pfizer said it had struck a "definitive merger agreement" with King at $14.25 per share, representing about a 40% premium to King's closing price on Oct. 11.

The acquisition "will advance Pfizer's strategic objectives by strengthening its position within the rapidly growing pain-relief market," the companies said.

"This strategic combination will allow Pfizer to leverage its existing commercial capabilities and expertise to create one of the leading broad portfolios for pain relief and management in the biopharmaceutical industry, offering both currently marketed opioid and non-opioid products, as well as a pipeline spanning stages of clinical development," said the New York City-based Pfizer and King, headquartered in Bristol, Tennessee.

Jeffrey Kindler, Pfizer CEO, said the tie-up in that area of "unmet medical need" was highly complementary.

The deal "will allow us to offer a fuller spectrum of treatments for patients across the globe who are in need of pain relief and management," he said.

Copyright Agence France-Presse, 2010

Popular Sponsored Recommendations

Empowering the Modern Workforce: The Power of Connected Worker Technologies

March 1, 2024
Explore real-world strategies to boost worker safety, collaboration, training, and productivity in manufacturing. Emphasizing Industry 4.0, we'll discuss digitalization and automation...

3 Best Practices to Create a Product-Centric Competitive Advantage with PRO.FILE PLM

Jan. 25, 2024
Gain insight on best practices and strategies you need to accelerate engineering change management and reduce time to market. Register now for your opportunity to accelerate your...

Transformative Capabilities for XaaS Models in Manufacturing

Feb. 14, 2024
The manufacturing sector is undergoing a pivotal shift toward "servitization," or enhancing product offerings with services and embracing a subscription model. This transition...

Shifting Your Business from Products to Service-Based Business Models: Generating Predictable Revenues

Oct. 27, 2023
Executive summary on a recent IndustryWeek-hosted webinar sponsored by SAP

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!